[1] Chierico F D,Nobili V,Vernocchi P.Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics based approach[J].Hepatology,2017,65(2):451-464. [2] Meex R C R,Watt M J.Hepatokines:linking nonalcoholic fatty liver disease and insulin resistance[J].Nature Reviews Endocrinology,2017,13(9):509-520. [3] Rocha A L L,Faria,L.C,Guimares,T.C.M,et al.Non-alcoholic fatty liver disease in women with polycystic ovary syndrome：systematic review and meta-analysis[J].Journal of Endocrinological Investigation,2017,40(12)：1279-1288. [4] Safiri S,Khazaei S,Mansori K,et al.Comments on increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease:Systematic review and meta-analysis[J].Hepatology,2017,65(5):1358-1359. [5] 胡虎兰,朱梦飞,施军平.慢性乙型肝炎合并非酒精性脂肪性肝病临床研究进展[J].实用肝脏病杂志,2019,22(1):149-152. [6] 黄娇凤,林苏,王明芳,等.恩替卡韦治疗慢性乙型肝炎合并非酒精性脂肪性肝病患者疗效及其对肝组织脂肪变的影响[J].实用肝脏病杂志,2018,21(6):863-867. [7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华内科杂志,2010,19(3)：1-3. [8] 胡梦琳,贾红宇,章晓莉,等.抗病毒/免疫调节新方案治疗HBeAg阳性初治慢性乙型肝炎患者的疗效观察[J].中华临床感染病杂志,2017,10(5):327-334. [9] Chan A W H,Wong G L H,Wong V W S.Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B Infection[J].Current Hepatology Reports,2017,16(2):97-104. [10] Kanto T,Yoshio S.Hepatitis Action Plan and Changing Trend of Liver Disease in Japan:Viral Hepatitis and Nonalcoholic Fatty Liver Disease[J].Euroasian Journal of Hepato-Gastroenterology,2017,7(1):60-64. [11] Chan A W H,Wong,Grace L H,Chan,Hoi-Yun,et al.Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B[J].J Gastroenterol Hepatol,2017,32(3)：667-676. [12] Han E,Lee Yong-ho.Non-Alcoholic Fatty Liver Disease:The Emerging Burden in Cardiometabolic and Renal Diseases[J].Diabetes Metab J,2017,41(6):430-437. [13] 焦运,马娟,王煜,等.双环醇联合恩替卡韦治疗慢性乙型肝炎合并非酒精性脂肪肝的疗效观察[J].宁夏医科大学学报,2017,39(8):953-956. [14] Vos M B,Abrams S H,Barlow S E,et al.NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children:Recommendations from the Expert Committee on NAFLD(ECON)and the North American Society of Pediatric Gastroenterology,Hepatology and Nut[J].J Pediatr Gastroenterol Nutr,2017,64(2):319-334. [15] 何佳,曾艳丽,李威,等非酒精性脂肪性肝病与其合并慢性乙型肝炎病毒感染的临床探讨[J].中华肝脏病杂志,2017,25(8):622-26. [16] Hou Y G,Xu Y,Bao J,et al.Factors affecting accuracy of controlled attenuation parameter by Fibrotouch in assessing hepatic steatosis[J].World Chinese Journal of Digestology,2017,25(19):1783-1787. [17] 翟力新. 胰酶肠溶胶囊和复方阿嗪米特肠溶片治疗酒精性脂肪肝合并消化不良的疗效[J].江苏医药,2011,37(17):2038-2040.
2023, Vol. 43 
